DXCM vs HOMB · P/E 63, rev $2.50B vs P/E 11, rev $647.9M
DexCom Inc (DXCM) versus Home BancShares Inc (HOMB) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Home BancShares Inc (HOMB) is a banks - regional company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported HOMB revenue for 2026-06-30 was $647.9M. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
Not investment advice. Open the DXCM and HOMB stock pages for the full models.
Not investment advice.